logo
Teva Pharm's second-quarter profit boosted by branded drugs, US tariff questions remain

Teva Pharm's second-quarter profit boosted by branded drugs, US tariff questions remain

Reuters30-07-2025
JERUSALEM, July 30 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26% rise in sales of its branded drugs and said it was well positioned to mitigate potential U.S. tariffs.
Richard Francis, CEO of Teva, the world's largest generic drugmaker, said there was "big ambiguity" and "so many unanswered questions" in the pharmaceuticals sector regarding potential U.S. import levies.
He added, however, that the Israel-based company, had been leveraging its U.S.-based manufacturing facilities and its minimal reliance upon China and India to soften the blow from any eventual tariffs.
"Those aspects just set us up in the face of this change, probably a lot better than our competitors," Francis told Reuters. "I feel we have the ability to put ourselves in a good position here, with the caveat - I need to know the details."
U.S. President Donald Trump initially threatened Israel with a 17% import tariff on its exports to the United States. But what will happen after his August 1 deadline expires remains unclear.
Global drugmakers also face the possibility of a sector-specific U.S. tariff on pharmaceuticals despite some drug shortages in the United States.
Teva said it earned 66 cents per diluted share, excluding one-time items, in the April-June quarter, up from 61 cents a share a year earlier. Revenue was flat in dollar terms at $4.18 billion.
Analysts had forecast earnings of 62 cents per share ex-items for the Israel-based company on revenue of $4.28 billion, LSEG I/B/E/S data showed.
Teva largely reaffirmed its 2025 estimates but revised its adjusted EPS forecast to $2.50-$2.65 from $2.45-$2.65.
It still projects revenue of $16.8 billion to $17.2 billion this year and said it was on track for 30% operating profit margin by 2027.
After a strong 2024, generic drugs were largely flat globally in the quarter, falling in the United States but offset by gains in Europe.
Among its branded drugs, sales of its Huntington's Disease treatment Austedo grew 19% to $498 million, while migraine medicine Ajovy rose 31% to $155 million and Uzedy, a drug to treat schizophrenia, jumped 120% to $54 million.
As a result, Teva raised its estimate for 2025 sales of Austedo slightly to $2 billion to $2.05 billion. It sees sales of Ajovy at $630 million to $640 million and Uzedy at $190 million to $200 million.
It added it would double biosimilar revenues from 2024 to 2027 and said it remained in negotiations to sell its active pharmaceutical ingredients unit.
Teva, Francis noted, has a large pipeline of drugs that will be launched in the coming decade - starting with schizophrenia drug Olanzapine in the fourth quarter - that combined will likely peak at more than $10 billion in sales.
Its New York-listed shares were up 2.9% at $17.15 in mid-morning trade.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

South Belfast to get new hotel and leisure development, while Ballymena gets bowling alley
South Belfast to get new hotel and leisure development, while Ballymena gets bowling alley

Belfast Telegraph

timea few seconds ago

  • Belfast Telegraph

South Belfast to get new hotel and leisure development, while Ballymena gets bowling alley

Permission was granted for the 164-bedroom Andras House hotel, which will have a ground floor bar and restaurant at the junction of Botanic Avenue and Donegall Pass. The site for the new hotel is currently used as a surface level car park and retail and office unit. Andras House acquired the site at Botanic Avenue in 2023 for £1.7m and last year it confirmed it is to develop a 164-room hotel for YOTEL, a London-based hotel firm. The project is estimated to be worth £17m. The Planning Committee also approved an application for change of use from office space and storage at Adelaide Business Centre. It will become a leisure development with bowling alley, restaurant, indoor golf, children's soft play, VR zone and amusements, with parking at the site. MK5 Ltd first unveiled plans for the leisure complex in 2022 after buying the Adelaide Business Centre on Apollo Road in Belfast for £1.35m. MK5 is owned by Patrick Simpson, the developer behind Londonderry's Brunswick Moviebowl leisure complex. Planning documents show that the estimated investment in the new project, in addition to the £1.35m to acquire the site, will be around £3m, with the businesses expected to create about 30 jobs. Permission was also given for the erection of a drive through café at lands near Lidl supermarket and Olympia Leisure Centre on the Boucher Road. Other applications approved were a council application for street art on the façade of the former Belfast Telegraph building in Royal Avenue at Donegall Street. Councillor Ryan Murphy, Chair of Belfast City Council's Planning Committee, said: 'It's further good news for tourists and visitors to Belfast to have another major hotel development approved, this time — in the Botanic area. 'This new hotel will be close to shops, bars and restaurants and other local visitor attractions like Botanic Gardens and the Ulster Museum. 'It's also walking distance to the city centre and close to Botanic station which provides public transport links to the wider city and beyond including Lanyon Place and St George's Market and Titanic Quarter and SSE Arena and Titanic Belfast, among other great attractions. 'The Planning Committee also approved a new leisure complex on the Apollo Road, Boucher, with bowling alley, soft children's play area and indoor golf which is fantastic news for residents and families in the city.' Meanwhile, Mid and East Antrim Borough Council has granted planning permission for a new bowling alley at a cinema complex in Ballymena. A proposal by applicant Carngore Ltd of Thomas Street, Ballymena, for renovations and an extension to the IMC Cinema to accommodate a 12-lane bowling alley and amusement centre has been given the go-ahead. A planning report noted the premises at St Patrick's Link Road are located just outside Ballymena in 'an established leisure area' adjacent to the Seven Towers Leisure Centre. The report said: 'The proposal is to change the use of two existing cinema rooms to provide an amusement area, further change of the existing lobby area and small extension to provide a bowling alley. 'Given the established leisure nature of the site and distance from any residential development, it is considered that there will be no impact on residential amenity or human health and well-being." The report stated that NI Water has recommended refusal. However, there is no proposed change to the existing water and sewerage facilities. 'Given the extensive parking on-site and adjacent at Seven Towers Leisure Centre, there is no need for any additional parking or traffic assessments.' There is no amendment to the access, it was noted.

Kenya central bank cuts rates for seventh time with inflation in target
Kenya central bank cuts rates for seventh time with inflation in target

Reuters

time19 minutes ago

  • Reuters

Kenya central bank cuts rates for seventh time with inflation in target

NAIROBI, Aug 12 (Reuters) - Kenya's central bank lowered its benchmark lending rate (KECBIR=ECI), opens new tab by 25 basis points on Tuesday, saying there was room to ease monetary policy further as inflation remains well within target. The Central Bank of Kenya (CBK) cut its policy rate to 9.50% from 9.75% previously, the seventh cut in a row. The decision was in line with the median forecast in a Reuters poll of economists. "The (Monetary Policy) Committee ... concluded that there was scope for a further easing of the monetary policy stance to augment the previous policy actions aimed at stimulating lending by banks to the private sector," the CBK said in a statement. Consumer inflation (KECPI=ECI), opens new tab rose to 4.1% year-on-year in July, compared with 3.8% the previous month, but it remains well within the central bank's preferred 2.5% to 7.5% band. Though price pressures have been contained, the East African country's public finances have been under pressure because of heavy debt repayments and revenue underperformance. The CBK left its economic growth forecasts for this year and next unchanged, at 5.2% and 5.4%, respectively. It also maintained its projection for this year's current account deficit, estimating it at 1.5% of gross domestic product (GDP) compared to 1.3% of GDP last year.

South Korea's Lee, Trump to hold August 25 summit on security alliance, economy
South Korea's Lee, Trump to hold August 25 summit on security alliance, economy

Reuters

time20 minutes ago

  • Reuters

South Korea's Lee, Trump to hold August 25 summit on security alliance, economy

SEOUL, Aug 12 (Reuters) - South Korean President Lee Jae Myung and U.S. President Donald Trump will hold their first summit meeting on August 25 in Washington to discuss strengthening the countries' alliance and economic security partnership, Lee's office said on Tuesday. Lee, who was elected president in a snap election in June, has made it a top priority to help his export-dependent country navigate the dramatic changes in the global trading environment triggered by Trump's tariff policies. "The two leaders will discuss ways to develop the U.S.-South Korea alliance into a comprehensive strategic alliance of the future in response to the changing international security and economic environment," presidential spokesperson Kang Yu-jung told a briefing. Based on the tariff deal reached last month, the two leaders will advance partnership in the manufacturing sector, including in semiconductors, batteries and shipbuilding, as well as critical minerals and technology, Kang said. A White House official also confirmed the meeting. Trump announced on July 30 that the countries had reached a trade deal that would subject South Korean goods to 15% import duties, lowering the tariff he had initially set against one of America's top trading partners. In return, Trump has said that South Korea will announce investment plans at the upcoming summit and that Seoul had committed to making $350 billion of investments to be "selected" by him. South Korean officials have offered differing details, however, and topics left unresolved by the deal - which has yet to be committed to writing - provide scope for more disputes between the allies. Trump may use the summit to seek more concessions on defence costs and corporate investments, left out of the deal, while non-tariff barriers and currency could prove thorny issues, experts said. Defence costs are expected to emerge as a key issue during the upcoming summit, with Trump having long said South Korea needed to pay more for the roughly 28,500 American troops based there as a legacy of the 1950-1953 Korean War. The Washington Post reported on Saturday that the Trump administration wanted Seoul to boost defence spending to 3.8 percent of GDP, up from 2.6 percent last year, and to increase its $1 billion-plus contribution toward the troops. Jeremy Chan, a senior analyst at the Eurasia Group, said it was unclear if such issues will be raised directly by Trump, but he said he expected that at least at the working level, discussions are going to move beyond trade and investment to the broader alliance. "I think it is more likely that Trump and his team are going to raise at least quietly, issues related to the security alliance," he said. "So that could be putting pressure on President Lee to increase the defence share of government spending."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store